S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kim, Hee Jin ^a,b   Chang, Keun A ^c   Ha, Tae Young ^a   Kim, Jeonga ^a   Ha, Sungji ^c   Shin, Ki Young ^a   Moon, Cheil ^d   Nacken, Wolfgang ^e   Kim, Hye Sun ^a   Suh, Yoo Hun ^a,b  

^a Seoul National University   (South Korea)

^b Korea Brain Research Institute (KBRI)   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALGRANULIN B; INTERLEUKIN 10; INTERLEUKIN 6; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; S100A9 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS BREEDING; FEMALE; GENE INACTIVATION; KNOCKOUT MOUSE; MALE; MEMORY DISORDER; MENTAL TASK; MORRIS WATER MAZE TEST; MOUSE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REFERENCE MEMORY; S100A9 GENE; SPATIAL MEMORY; TG2576 MOUSE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DEGENERATIVE DISEASE; DISEASE MODEL; GENETICS; METABOLISM;

AMYLOID BETA-PEPTIDES; ANIMALS; CALGRANULIN B; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897811114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088924     Document Type: Article

References (59)

1. Fritz G, Botelho HM, Morozova-Roche LA, Gomes CM (2010) Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J 277: 4578-4590.
2. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Ejso 34: 357-364. (Pubitemid 351381290)
3. Roltsch E, Holcomb L, Young KA, Marks A, Zimmer DB (2010) PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation. J Neuroinflammation 7: 78.
4. Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, et al. (2010) Overexpression of Human S100B Exacerbates Cerebral Amyloidosis and Gliosis in the Tg2576 Mouse Model of Alzheimer's Disease. Glia 58: 300-314.
5. Boom A, Pochet R, Authelet M, Pradier L, Borghgraef P, et al. (2004) Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochimica Et Biophysica Acta-Molecular Cell Research 1742: 161-168. (Pubitemid 39601776)
6. Mrak RE, Griffin WST (2001) The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging 22: 915-922. (Pubitemid 34066559)
7. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, et al. (2009) Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One 4: e5562.
8. Ha TY, Chang KA, Kim JA, Kim HS, Kim S, et al. (2010) S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model. PLoS One 5.
9. Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, et al. (2006) Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol Aging 27: 1554-1563. (Pubitemid 44344843)
10. Nacken W, Mooren FC, Manitz MP, Bode G, Sorg C, et al. (2005) S100A9 deficiency alters adenosine-59-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. Int J Biochem Cell Biol 37: 1241-1253. (Pubitemid 40381200)
11. Nacken W, Roth J, Sorg C, Kerkhoff C (2003) S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60: 569-580.
12. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT (2010) Inflammation and Alzheimer's disease. Arch Pharm Res 33: 1539-1556.
13. Querfurth HW, Laferla FM (2010) Alzheimer's Disease REPLY. New England Journal of Medicine 362: 1844-1845.
14. Supnet C, Bezprozvanny I (2010) The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 47: 183-189.
15. Giannakopoulos P, Kovari E, Gold G, von Gunten A, Hof PR, et al. (2009) Pathological substrates of cognitive decline in Alzheimer's disease. Front Neurol Neurosci 24: 20-29.
16. Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15: 349-357.
17. Kayed R, Lasagna-Reeves C (2012) Molecular Mechanisms of Amyloid Oligomers Toxicity. J Alzheimers Dis.
18. Glabe CG (2008) Structural Classification of Toxic Amyloid Oligomers. Journal of Biological Chemistry 283: 29639-29643.
19. McDonald JM, Savva GM, Brayne C, Welzel AT, Forster G, et al. (2010) The presence of sodium dodecyl sulphate-stable A beta dimers is strongly associated with Alzheimer-type dementia. Brain 133: 1328-1341.
20. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Annals of Neurology 46: 860-866.
21. Apelt J, Schliebs R (2001) beta-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Research 894: 21-30. (Pubitemid 32197594)
22. Wilson EH, Wille-Reece U, Dzersznski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Journal of Neuroimmunology 165: 63-74. (Pubitemid 40984624)
23. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, et al. (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20: 187-198. (Pubitemid 41476246)
24. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203-1218.
25. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, et al. (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22: 1858-1867. (Pubitemid 35386304)
26. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, et al. (2001) Age-dependent changes in brain, CSF, and plasma amyloid beta protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 21: 372-381. (Pubitemid 32107428)
27. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56: 965-973. (Pubitemid 27386126)
28. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, et al. (1996) Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102. (Pubitemid 26332733)
29. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408: 979-982. (Pubitemid 32101644)
30. Chen G, Chen KS, Knox J, Inglis J, Bernard A, et al. (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408: 975-979. (Pubitemid 32101643)
31. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, et al. (2003) Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro. Molecular and Cellular Biology 23: 1034-1043. (Pubitemid 36133519)
32. Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, et al. (2012) Toxoplasma gondii Infection in the Brain Inhibits Neuronal Degeneration and Learning and Memory Impairments in a Murine Model of Alzheimer's Disease. PLoS One 7: e33312.
33. Shin KY, Lee GH, Park CH, Kim HJ, Park SH, et al. (2007) A novel compound, maltolyl p-coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models. Journal of Neuroscience Research 85: 2500-2511.
34. Shen Z, Wang G, Lin SZ (1990) Two-way shuttlebox avoidance conditioning and brain NADH in rats. Physiol Behav 48: 515-517. (Pubitemid 20370855)
35. Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribe E, et al. (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Current Alzheimer Research 2: 3-18. (Pubitemid 41389255)
36. Avila J, Lim F, Moreno F, Belmonte C, Cuello AC (2002) Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol Neurobiol 25: 213-231. (Pubitemid 34665091)
37. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-1159. (Pubitemid 32695256)
38. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33: 95-130.
39. Spillantini MG, Goedert M (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21: 428-433. (Pubitemid 28449072)
40. Tomidokoro Y, Harigaya Y, Matsubara E, Ikeda M, Kawarabayashi T, et al. (2001) Brain A beta amyloidosis in APPsw mice induces accumulation of presenilin-I and tau. Journal of Pathology 194: 500-506. (Pubitemid 32782677)
41. Masliah E, Sisk A, Mallory M, Games D (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. J Neuropathol Exp Neurol 60: 357-368. (Pubitemid 32274051)
42. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94: 13287-13292. (Pubitemid 27518514)
43. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B (1994) Transgenic mouse brain histopathology resembles early Alzheimer's disease. Annals of Neurology 35: 598-607. (Pubitemid 24153844)
44. Mellins ED, Macaubas C, Grom AA (2011) Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nature Reviews Rheumatology 7: 416-426.
45. Mehlhorn G, Hollborn M, Schliebs R (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. International Journal of Developmental Neuroscience 18: 423-431. (Pubitemid 30243072)
46. Hoyaux D, Decaestecker C, Heizmann CW, Vogl T, Schafer BW, et al. (2000) S100 proteins in Corpora amylacea from normal human brain. Brain Res 867: 280-288. (Pubitemid 30317409)
47. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364. (Pubitemid 351381290)
48. van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, et al. (2008) Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 67: 1750-1758.
49. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8 + T cells. Nat Med 16: 713-717.
50. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049. (Pubitemid 47517513)
51. Liu JL, Wang HL, Zhang LF, Xu YF, Deng W, et al. (2011) S100B Transgenic Mice Develop Features of Parkinson's Disease. Archives of Medical Research 42: 1-7.
52. Li CY, Zhao R, Gao K, Wei Z, Yin MY, et al. (2011) Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimer's Disease. Current Alzheimer Research 8: 67-80.
53. Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW (2005) S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J Neurochem 92: 546-553. (Pubitemid 40189458)
54. Li Y, Wang J, Sheng JG, Liu L, Barger SW, et al. (1998) S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 71: 1421-1428. (Pubitemid 28443012)
55. Sheng JG, Mrak RE, Griffin WST (1997) Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1 alpha(+) microglia and S100 beta(+) astrocytes with neurofibrillary tangle stages. Journal of Neuropathology and Experimental Neurology 56: 285-290. (Pubitemid 27461169)
56. Chang KA, Kim HJ, Suh YH (2012) The role of s100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of s100a9 knockdown or knockout. Neurodegener Dis 10: 27-29.
57. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3: 75-80.
58. Suh YH, Checler F (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: Molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacological Reviews 54: 469-525.
59. Eggers K, Sikora K, Lorenz M, Taubert T, Moobed M, et al. (2011) RAGE-Dependent Regulation of Calcium-Binding Proteins S100A8 and S100A9 in Human THP-1. Experimental and Clinical Endocrinology & Diabetes 119: 353-357.